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Laser capture microdissectionRabbit oral papillomavirus (ROPV) causes benign and spontaneously regressing oral lesions in rabbits, and is a
useful model of disease associated with low-risk human papillomavirus types. Here we have adapted the ROPV
system to study papillomavirus latency. Following lesion regression, ROPV DNA persists at the majority of
regressed sites at levels substantially lower than those found in productive papillomas. Spliced viral transcripts
were also detected. ROPV persistence in the absence of disease could be demonstrated for a year following
infection and lesion-regression. This was not associated with completion of the virus life-cycle or new virion
production, indicating that ROPV persists in a latent state. Using novel laser capture microdissection techniques,
wecould showthat the site of latency is a subset of basal epithelial cells at sites of previous experimental infection.
We hypothesize that these cells are epithelial stem cells and that reactivation of latency may be a source of
recurrent disease.).
 license.© 2011 Elsevier Inc. Open access under CC BY license.Introduction
Manyviruseshave a latent stage to their life cycle that is typiﬁedby the
presence of virus in the absence of clinical signs of disease (Kane and
Golovkina, 2010). During latent infection, the production of new virus
particles is restricted, and the viral genome is maintained in a silent state
with little or no gene expression. Reactivation from latency generally
allows the formation of a productive infection, with or without the re-
emergence of a visible lesion (Rajcani, 2007). It is considered likely that
papillomaviruses form latent infections (Broker et al., 2001;Nicholls et al.,
2001; Stubenrauch and Laimins, 1999). The high post-treatment
recurrence rates of genital papillomas caused by low-risk HPV types
(HPV-6 and HPV-11) suggest that latent infections may occur in genital
tissues (Lacey, 2005). HPV-11 and HPV-6 are also responsible for the
formationofpapillomas in theairwaysofpatients suffering fromrecurrent
respiratory papillomatosis (RRP) (Gissmann et al., 1982; Mounts et al.,
1982). RRP is associated with benign papillomas of the larynx, which can
recur repeatedly despite surgical intervention. Viral latency has also been
proposed as a potential factor responsible for recrudescence, with viral
DNA and RNA transcripts often being found in clinically normal tissues of
RRP patients (Abramson et al., 2004; Maran et al., 1995; Pignatari et al.,
1992; Smith et al., 1993). In addition, there is emerging evidence thatHPV
may be present in the cervical mucosa in the absence of clinical signs of
disease and at low copy numbers, again hinting at the possibility of latent
infection (Kalantari et al., 2009).Studies of animal models of papillomavirus infection have further
demonstrated the ability of papillomaviruses to persist in the absence of
clinical signs of disease. Infection of the skin of domestic rabbits with
cottontail rabbit papillomavirus (CRPV) can induce an asymptomatic
infection, characterized by the persistence of viral DNA in the absence of
visible signs of disease (Amella et al., 1994; Zhang et al., 1999).
Furthermore, asymptomatic infection was shown to be associated with
the production of E1 transcripts, which are thought to be required for
the stable maintenance of viral genomes in infected epithelial cells.
Exposure toexogenous factors suchasultraviolet light could activate the
virus leading to the emergence of clinical lesions (Zhang et al., 1999).
Most CRPV papillomas do not spontaneously regress, but when
complete regression does occur, CRPV DNA can be detected in clinically
normal tissues (Selvakumar et al., 1997). Persistence of DNA is at low
copy number consistent with only a subset of cells harboring viral
genomes. Similarly, it has been suggested that canine oral papilloma-
virus may form a latent infection with DNA detected following the
regression of papillomas in the absence of clinical signs of disease and at
low copy number (Stanley et al., 2001).
We chose the infection of domestic rabbits with rabbit oral
papillomavirus (ROPV) as a model system to further study papilloma-
virus latency. ROPV is a naturally occurring infection of domestic rabbits
that leads to the formation of benign papillomas in the oral cavity
(Parsons and Kidd, 1943; Sundberg et al., 1985). Lesions undergo
spontaneous immune-mediated regressionand, in contrast toCRPV, have
not been reported to undergo neoplastic transformation (Reuter et al.,
2001; Syverton, 1952). Therefore ROPV is a more suitable model of low-
risk HPV disease than CRPV. Furthermore, unlike COPV and CRPV, ROPV
can infect the genital epithelium(Christensen et al., 2000) andhas amore
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that are thought to have a latent phase such as HPV-11 (Peh et al., 2002).
In this study, we have developed the ROPV system to study papilloma-
virus latency following immune regression. We show that ROPV persists
in the absence of clinical andmicroscopic signs of disease for up to a year
following the resolution of disease. The detection of viral DNA andRNAat
regressed sites appears to be largely conﬁned to the basal epithelial cells,
and is not generally associatedwith completion of the virus life cycle and
theproductionofnewvirions.Our results suggest thatROPVgenomesare
maintained in a latent infection at levels that are compatible with
persistence in the basal stem cell. We hypothesize that the virus may be
capable of reactivation under certain conditions.Results
Formation of papillomas following experimental infection with ROPV
Our primary goalwas to establish the fate of viral genomes following
the immune regression of ROPV papillomas. We therefore sought a
means of permanently and accurately identifying areas of the tongue
tissue that had previously undergone experimental infection with
ROPV, and differentiating them from adjacent regions that had not been
infected. A previous study demonstrated that by pin-pricking the
undersurfaceof the tonguewith ahypodermic needle and then applying
ROPV virions, discrete papillomas measuring 1 mm in size formed at
more than75%of sites (Embers et al., 2002).Wemodiﬁed this technique
by pinpricking the tongue with a mixture of ROPV virions and black
tattoo ink. Using this modiﬁed technique, we also found that visible
papillomas formed at 75% of tattoo-marked infected sites but did not
appear at uninfected sites. Typically, papillomas were ﬁrst evident by
visual inspection at 2 weeks post-infection. At this time, the tonguewas
completely healed following the infection procedure and papillomas
appeared as small raised and translucent lesions that were associated
withnonoticeable inﬂammation. They continued togrowuntil between
4 and 6 weeks post-infection reaching a maximum size of approxi-
mately 2 mm (Fig. 1A). At this time, they had a prominent exophytic
appearance with the tattoo mark clearly visible in the underlying
tissues. Detrimental effects on general rabbit health, appetite and bodyFig. 1. Formation of papillomas following experimental infection. The mucosa of the ventra
tattoo ink. The gross (row A) and histological (row B) appearance of lesions is shown at 4, 6
stained cryosections obtained after culling of animals. The locations of tattoo ink on H&E stcondition were not apparent. Around 6 weeks post-infection, immune-
mediated regressionwas apparent, andwas associatedwith a reduction
in papilloma size and number, and with complete resolution of
papillomas by 8 weeks post-infection. At this time point, the epithelium
resumed a normal appearance (other than for the presence of tattoo
marks) as determined by gross visual and microscopic examination of
tissue sections. We did not observe the formation of visible papillomas
at any regions of the lingual mucosa that had not been experimentally
infected. Furthermore, papillomas did not form elsewhere within the
oral cavity. The location of papillomas was found to correlate very
closely with the location of tattoo marks as determined by visual
inspection, and tattoo marks were still readily visible as late as a year
following experimental infection. Microscopic examination conﬁrmed
that tattoo marks were easily visible in the dermis immediately
underlying papillomas and that they continued to localize sites of
experimental infection beyond the regression of papillomas (Fig. 1B).
Addition of tattoo ink did not appear to inﬂuence the progression of
infection,with identical papillomas formingand regressingconcurrently
at tattoo-marked and unmarked sites in the same rabbit (data not
shown). The tattoo marking technique appears useful therefore, for
accurately identifying sites of experimental infection following the
regression of papillomas, both by gross inspection and by microscopy.Detection of ROPV DNA
During the productive stages of the ROPV life cycle, ROPV DNA was
readily detectable by ﬂuorescent in situ hybridization (FISH). ROPV DNA
was ﬁrst seen in the intermediate to upper layers of the epithelium, and
was coincident with the expression of the ROPV E1^E4 protein as
determined by indirect immunoﬂuorescence staining (Fig. 2A and B). As
found previously, ROPV DNA was not detected in the basal epithelial
layers using this approach, (Pehet al., 2002),whichmost probably reﬂects
the limited sensitivity of the technique. Following papilloma regression,
ROPVDNAcouldnotbedetected inanyof theepithelial layersusing in situ
hybridization, suggesting that ROPV genome ampliﬁcationwas no longer
occurring in the mid to upper epithelial layers, or that it was below the
limits of detection using this approach. The failure to detect viral DNA in
the basal layers does not rule out its presence at low copy number, butl surface of the tongue was infected using a crude papilloma homogenate mixed with
and 8 weeks post-infection by photographs taken under general anaesthesia and H&E
ained sections are shown by arrows.
Fig. 2. Fluorescent in situ hybridization of ROPV DNA. Presence of ROPV DNA was determined in tissue sections from experimentally infected rabbits using a full-length DIG-labeled
probe. Sections were also stained for the presence of ROPV E1^E4 protein. The basal layer of epithelial cells is marked by a dotted line. Fluorescent images are shown for a productive
papilloma at 4 weeks post-infection at ×10 (row A) and ×20 (row B). Detection of ROPV DNA generally coincides with expression of E1^E4 protein. ROPV DNA is not visible in the
basal layers of the epithelium. At 8 weeks post-infection (row C) following the regression of papillomas, ROPV DNA and E1^E4 protein are no longer visible.
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in situhybridizationmethods.Wedecided therefore touseaLaserCapture
Microdissection (LCM) approach to determine whether ROPV DNA is
indeed present and at what level.
Our LCM technique was optimized on tissue sections taken from
rabbits with papillomas, allowing us to quantify DNA copy number
during productive infection. Using LCM, papillomas were divided into
seven stratiﬁed layers from the basal layer to themucosal surface. Using
this approach, ROPVDNAwas readily detectable in thebasal layers of the
epithelium despite the absence of a positive in situ signal (Fig. 3 layer 1).
However, we were unable to detect ROPV in the basal layers of the
epithelium immediately adjacent to the papilloma (Fig. 3 layer C)
consistentwith the absenceof infection in these tissues.Moving fromthe
basal layers toward the surface of the papilloma, there was a gradual
increase in ROPV DNA copy number relative to the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) reference gene, indicative of
ampliﬁcation of viral DNA. The highest levels of ROPV DNA were
therefore observed in the uppermost layers of the epithelium and were
indicative of a ﬁve log-fold ampliﬁcation of viral DNA compared to the
basal-most layers (Fig. 3 layer 7).We consistently detected similar levels
of ROPV DNA ampliﬁcation in the sections obtained from the same
papilloma and from other papillomas. Most notably, we failed to detectROPV DNA in normal epithelium adjacent to papillomas, despite
papillomas containing veryhigh levels of viral DNA. This further suggests
that following experimental infection, the detection of ROPV genomes
was limited only to the infected sites. It appears that the LCMapproach is
useful in amplifying and detecting ROPV DNA that is below the limits of
detection using conventional in situ hybridization methodology.
Persistence of ROPV DNA following the regression of papillomas
Wenext sought to determinewhether or not ROPVDNApersisted in
tongue tissue following the regression of papillomas, possibly as a latent
infection. Ten rabbitswere infectedwith ROPV and a further two rabbits
served as negative controls. Control rabbits underwent pinpricking and
tattooing of the tongue but with the application of phosphate buffered
saline in place of ROPV virus suspension. At 4 weeks post-infection, the
oral cavities of all animals were thoroughly examined under general
anesthesia. The presence of visible papillomas was conﬁrmed in all ten
ROPV-infected rabbits, whereas none were visible in the two control
animals (Table 1 column3). Two of the ROPV-infected rabbits (rabbits A
andB)were culled at this timepoint to determine theviral copynumber
in productive lesions. The remaining rabbits were subsequently
examined every 4 weeks to determine whether papillomas were
Table 1
Summary data from infected rabbits.
Rabbit data Gross
examination
Whole tissue
biopsies
Tissue sections
Papillomas
visible
ROPV DNA detected Infected sites
Rabbit WPI 4
WPI
Time of
culling
Infected
sites
Uninfected
sites
ROPV
DNA
in basal
cells
Normal
epithelium
L1/E4
protein
and
MCM7
A 4 Yes Yes 5/5 5/5 – – –
B 4 Yes Yes 5/5 5/5 – – –
C 10 Yes No 5/5 5/5 3/4 4/4 0/4
D 10 Yes No 5/5 5/5 – – –
E 15 Yes No 5/5 1/5 2/5 5/5 0/5
F 15 Yes No 4/5 0/5 0/5 5/5 0/5
G 19 Yes No 5/5 1/5 2/5 5/5 0/5
H 19 Yes No 2/5 0/5 3/4 4/4 0/4
I 22 Yes No 4/5 0/5 6/6 6/6 0/6
J 22 Yes No 5/5 0/5 2/8 8/8 0/8
Cont 1 14 No No 0/5 0/5 – – –
Cont 2 24 No No 0/5 0/5 – – –
Summary data for ROPV infected rabbits. Ten rabbits were infected with ROPV and two
rabbits served as uninfected controls. Rabbits were culled at varying weeks post-
infection (WPI). Rabbits were examined at 4WPI and at the time of culling to determine
whether or not papillomas were visible (columns 3 and 4). After culling, ﬁve whole
tissue biopsies were analyzed from tattoo marked infected and from uninfected sites.
The number of sites where ROPVDNAwas detected in biopsies is shown (columns 5 and
6). A further 4–8 tattoo-marked sites were sectioned and basal cells dissected for real-
time PCR analysis of ROPV DNA. The number of tattoo-marked sites from each rabbit
that were positive for ROPV DNA in basal cells is shown (column 7). Adjacent sections
were stained with H&E to assess pathology (column 8) and for the presence of L1, E1^E4
and MCM7 proteins (column 9). The number of sites at which viral L1 and E1^E4
proteins were detected and at which MCM7 expression was detected above the normal
basal layer levels is shown.
Fig. 3. Detection of ROPV in papillomas using LCM. LCM was used to dissect seven (1 to 7) sequential layers of epithelial cells from papillomas harvested at 4 weeks post-infection
(A). Uninfected adjacent control samples (layer C) were also obtained. DNA was extracted and real-time PCR performed for quantiﬁcation of ROPV DNA and GAPDH reference gene.
The graph in image B shows a ratio of ROPV copy to GAPDH copy number (with standard error) for each corresponding layer shown in image A. ROPV DNAwas not detected in basal
layer samples (layer C) taken immediately adjacent to papillomas (*). ROPV DNA was always detected in basal layer samples obtained from papillomas (layer 1). A gradual rise in
ROPV DNA copy number was seen between the basal layers and the epithelial surface within papillomas. The degree of ampliﬁcation was approximately four to ﬁve log-fold.
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culled at 14 and 24 weeks post-infection. For ROPV-infected animals, all
papillomas had regressed by 8 weeks post-infection (as determined by
visible inspection) and did not subsequently recur at any of the four-
weekly examinations (Table 1 column 4). In this cohort of rabbits, we
did not observe spontaneous ROPV reactivation and lesion formation
following immune regression.
Rabbits were culled and tissue samples were dissected from ﬁve
tattoo-marked ROPV-infected sites, and from ﬁve regions of the tongue
that had not been experimentally infected to allow quantiﬁcation of
viral DNA by real-time PCR. In tissue biopsies obtained from productive
papillomas at 4 weeks post-infection (rabbits A and B), the presence of
ROPV DNA was conﬁrmed in all biopsies taken from tattoo-marked
ROPV-inoculated sites (Table 1 column 5). ROPV copy numberwas very
high at sites bearing visible papillomas, with 104 to 105 copies of ROPV
DNA per copy of GAPDH (Fig. 4). In rabbits with regressed papillomas
culled at 10, 15, 19 and 22 weeks post-infection (rabbits C to J) we
detected ROPV DNA at the majority (88%) of ROPV-inoculated sites
(Table 1 column 5). However, for these rabbits (which no longer bear
visible papillomas), ROPV DNA copy numbers were between six and
nine log-fold lower at 10−5 to 10−2 copies of ROPV DNA per copy of
GAPDH compared to productive infection (Fig. 4). In both rabbits culled
at 10 weeks post-infection (rabbits C and D), we could still detect ROPV
DNA in tissue samples taken from regions of the tongue that had not
undergone experimental infection, although copy numbers were 10 to
100 fold lower than at infected sites (Table 1 column 6 and Fig. 4). It is
possible that not all papillomas had undergone complete regression
and/or that a low level productive infection may have been present
elsewhere in the oral cavity. Beyond 10 weeks post-infection ROPVDNA
was only occasionally detected (7% of sites) and copy number was
always lower than at equivalent tattoo-marked infected sites from the
samerabbit (Fig. 4). Fromthesedata,we cannot eliminate thepossibility
that some of these sites had inadvertently become infected with ROPV
either at the time of experimental infection or in the weeks afterward
when adjacent papillomas were shedding large amounts of ROPV
virions. It is clear however that ROPV can persist at the sites of previous
infection long after visible signs of lesion-presence have gone.
LCM analysis of latently infected tissues
Whole tissue analysis allowed us to monitor ROPV persistence
following lesion regression. To understand this more thoroughly, wenext sought to localize the site of persistence. As tissue biopsies comprise
a heterogeneous population of different cell typeswe focused oncemore
on the laser capture microdissection approach. Between four and eight
tattoo-marked tissue sites were identiﬁed in biopsy material collected
from rabbits culled at 10, 15, 19 and 22 weeks post-infection (rabbits C
to J). These were sectioned using a cryostat, and one section from each
site was stainedwith hematoxylin and eosin to establish the integrity of
the epithelium. Further sections were subjected to indirect immunoﬂu-
orescence staining using anti-L1, E1^E4 and MCM7 antibodies.
Fig. 4. ROPV DNA copy number at infected and uninfected sites. Pairs of rabbits infected with ROPV were culled at successive intervals. ROPV DNA copy number was determined
relative to GAPDH at ﬁve experimentally infected and ﬁve uninfected sites after culling. The average ratio of ROPV DNA to GAPDH reference gene is shown with standard error.
Samples marked * indicates that no ROPV DNAwas detected in any of the ﬁve samples. Two control rabbits underwent scariﬁcation but were not infected with ROPV. ROPV DNAwas
not detected at any of the scariﬁed or non-scariﬁed sites.
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determine whether or not the late stages of the virus life-cycle, and
new virion production could be detected post-regression. Detection of
the cellular MCM7 protein was used as a surrogate marker for viral E7
protein expression, and was considered to be an indicator of early life
cycle events when the protein was present in the suprabasal cell layers.
Neithermicroscopic papillomas nor detectable productive infectionwas
apparent in any of the samples taken from the 10-, 15-, 19- or 22-week
rabbits (Table 1 columns 8 & 9). Similarly, therewas no evidence of cells
in cycle above the basal layers of the epithelium except in the
productively infected 4-week rabbits (as shown in Fig. 2). Remaining
sectionswere cut onto PENmembrane-slides, with six adjacent sections
placed onto each slide. Basal cells overlying tattoomarkswere dissected
from all six sections using LCM (Fig. 5) and pooled together for analysis.
Thus in total, DNA was extracted from between 1000 and 2000 basal
cells. Real-time PCR analysis showed that in a total of 37 tattoo-marked
experimentally infected sites taken from seven rabbits, ROPV DNA was
present in the basal epithelial cells of 18 (49%) cases (Table 1 column 7).
For each of the samples in which ROPV DNA was present in basal cells,Fig. 5. Collection of LCM samples from tissue sections. Sites of experimental infection were i
The following tissue samples were selected for dissection using LCM (A): blank slide membra
basal epithelial cells from immediately above the tattoo mark (red). Tissue samples were cthree separate control samples were also analyzed (Fig. 5). Pieces of
blank PEN membrane adjacent to tongue tissue sections were also
dissected. Allmembrane-control sampleswerenegative for thepresence
of ROPV DNA (Table 2 column 2), therefore ruling out contamination of
slides and reagents with ROPVDNA. Samples of stromal tissuewere also
dissected from beneath the tattoo-marked sites. The size of the pieces of
tissue dissected was always greater in surface area than the size of the
corresponding basal cell samples collected. Stromal tissue samples were
again always negative for the presence of ROPVDNA (Table 2 column3),
therefore eliminating the presence of contaminating ROPV DNA on the
tissue section and ruling out the presence of latent ROPV in the dermal
tissues underlying experimentally infected sites. Finally, an equivalent
number of basal cells were collected from areas of the same tissue
sections that had not been experimentally infected. Of the 18 samples
collected, low levels of ROPV DNA were detected in only one (5.6%) of
these (Table 2 column4). ROPVDNAcopynumberwas lower than in the
corresponding basal cell sample taken from the experimentally infected
site. Given that our control samples eliminated the presence of ROPV
DNA contamination on slides and tissue sections, it is possible that adentiﬁed by means of tattoo marks (arrowheads) on tissue H&E stained tissue sections.
ne (blue), stromal tissue (yellow), uninfected adjacent basal epithelial cells (green) and
ollected using LCM into microcentrifuge tubes (B).
Table 2
Detection of ROPV DNA in LCM samples.
Rabbit—
sample no.
Control samples—copies ROPV/100 cells
Membrane Stroma Epithelium Basal cells Upper layers
C-1 0 0 0 5.2 N/A
C-2 0 0 0 1.0 0
C-3 0 0 0 2.9 N/A
E-1 0 0 0 436.0 460455
E-2 0 0 0 192.9 N/A
G-1 0 0 0 4.9 0
G-2 0 0 0 4.7 N/A
H-1 0 0 0 25.0 0
H-2 0 0 0 96.2 0
H-4 0 0 0 631.0 0
I-1 0 0 0 2.1 0
I-3 0 0 0 9.1 0
I-4 0 0 0 1.8 0
I-6 0 0 0 8.3 0
I-8 0 0 0 17.4 0
I-9 0 0 0 4.9 0
J-1 0 0 0 11.4 0
J-3 0 0 1.6 4.7 N/A
Average 0 0 0.15 81.1
Between four and eight basal cell samples were collected using LCM from the ROPV-
infected rabbits shown in Table 1 and determination of ROPV DNA and GAPDH copy
number were performed. The ROPV DNA copy number expressed per 100 cells is shown
for 18 samples in which ROPV DNA was detected. For each of these sections, samples of
uninfected epithelial basal cells, stromal tissue and blank slide membrane were
collected. Attempts were also made to collect the upper epithelial layers above the
infected basal cells although this was not always possible for technical reasons. The
average ROPV DNA copy number per 100 cells is shown.
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sample was obtained from this tissue section and was negative for the
presence of ROPV DNA.
ROPV DNA copy numbers in basal cell samples taken from
experimentally infected sites were generally very low. The mean and
median copy numbers per cell were 81.1 and 6.8 respectively. The high
mean value was due to high copy numbers in four samples obtained
from rabbits E andH.However, for 83% (15/18) of the samples therewas
less than one copy of ROPV DNA per cell. This would be consistent with
latent genomes being present in only a subset of basal epithelial cells.
Where ROPV DNA was present in basal cells at experimentally
infected sites, we also examined the remaining layers of the epithelium
using LCM (Fig. 5) to establish whether there was any evidence of
genome ampliﬁcation. For technical reasons (insufﬁcient sample
recovery) it was only possible to do this for 13 of the 18 samples (78%).
For 12 of these 13 samples (92%) wewere unable to detect ROPV DNA in
the upper epithelial layers, even though viral genomes were apparent in
the basal layer. In these cases, the presence of ROPV in the basal cells did
not appear to be associated with the persistence or ampliﬁcation of DNA
in the upper epithelial layers. In one sample however (E-1) copy number
per cell was approximately 1000 fold higher in the upper layers
compared to the basal cells. Examination of adjacent sections for the
presence of L1 and E1^E4 proteins by immunoﬂuorescence and by light
microscopy suggested that a productive infection was not present. LCM
was also performed on another adjacent section and ROPV DNAwas not
detected in the upper layers despite being present in basal cells. Itmay be
that ampliﬁcation of ROPV DNA in sample E-1 was representative of a
sporadic productive infection occurring in only a small subset of infected
cells.
Occasionally ROPV DNA was detected in the whole tissue biopsies
suggesting that a latent infection had formed but ROPV DNA was not
detected in basal cell samples analyzed using our LCM approach. It is
likely some of these sites did indeed contain viral genomes but below
the levels detectable using ourmethods. Otherwise, our LCMwas highly
successful in localizing viral genomes to the basal layers of the
epithelium at sites of previous experimental infection.Long-term persistence of ROPV latency
The analysis of tissue from this ﬁrst cohort of rabbits showed that
ROPV DNA can persist until at least 22 weeks post-infection, and that
viral genomes can be detected 14 weeks after lesion regression. ROPV
copy number generally appeared to be higher in rabbits culled at 10 and
15 weeks post-infection as compared to rabbits culled at 19 and
22 weeks post-infection. We therefore sought to determine whether
ROPV copy number continued to progressively declinebeyond22 weeks
post-infection, andwhether latent genomesmight eventually disappear
altogether. To look at this further, 11 rabbits (rabbits K to U) were
infected with ROPV. In addition to our tattoo-marking and infection
technique, several tongue sites per rabbit were infected in an identical
manner but minus tattoo ink. Three rabbits were culled at 2, 3 and
4 weeks post-infection (rabbits K, L and M respectively) to determine
ROPV DNA copy number during productive infection. Subsequently,
rabbitswere culled at intervals upuntil 1 yearpost-infection. Five tattoo-
marked experimentally infected sites were harvested from each animal
and ROPV DNA copy number determined by real-time PCR (Fig. 6).
Again, rabbitswere examined at 4 and 8 weeks post-infection to conﬁrm
that papillomas had formed and regressed in all animals. Subsequent
four-weekly examinations showed that the spontaneous re-emergence
of visiblepapillomashadnot occurred. In sevenof the eight rabbits culled
following papilloma regression, ROPV DNA was detectable at tattoo-
marked sites. Importantly, ROPV DNA was still detectable in one rabbit
culled at 1 yearpost-infection (rabbitU). In one rabbit culled at 34 weeks
post-infection (rabbit R), ROPV DNA was not detected at any site that
had undergone experimental infection with ROPV, despite papillomas
being visible at 4 weeks post-infection. It is possible that a latent
infection had failed to establish in this rabbit or that latent infection had
been effectively cleared by the immune system. Additionally, a tissue
sample was taken from the infected but non-tattooed region of the
tongue. This showed that where ROPV DNA was detected at tattoo-
marked sites, it was also detected at unmarked sites. Therefore presence
of tattoo ink did not inﬂuence the persistence of viral DNA.
Detection of ROPV transcription at sites of latent infection
Todeterminewhether or not persistence of ROPVDNA following the
regression of papillomas was associated with active transcription of the
viral genome, an RT-PCR assay was designed to amplify spliced
transcripts spanning the major E1^E4 splice site. The ROPV genome
sequence was compared to the HPV 11 genome (Genbank accession
numbers AF227240 and NC_001525) and the location of the E1^E4
splice site was predicted. PCR carried out using the E1^E4 primer set on
cDNA from productive papillomas (as described in Materials and
methods section) identiﬁed the splice donor site at nucleotide 1152 and
the splice acceptor at nucleotide 3540 within the ROPV genome. The
same primers were used for our real-time PCR assay and we conﬁrmed
that cDNA but not ROPV genomic DNA was ampliﬁed. Using ROPV
genomes as template, noPCRproductwasdetected byour real-timePCR
assay. Biopsies of experimentally infected tongue tissue were obtained
from rabbits in the second time-course experiment (rabbits K to U). As
expected, spliced RNA transcripts were detected in abundance during
productive infection atweeks two, three and four post-infection (Fig. 6).
Following the regression of papillomas, spliced transcripts were still
detected in ﬁve of the eight rabbits, andmost notably were still present
at 1 year post-infection in rabbit U. In contrast, no ampliﬁcation was
detected by real-time PCR in uninfected control tissues, “no reverse
transcriptase” controls and in no-template controls. Spliced transcripts
were not detected in three rabbits culled at 34, 38 and 47 weeks post-
infection (rabbits R, S and T respectively). At 34 weeks post-infection
(rabbit R), both ROPV DNA and ROPV transcripts were undetectable
suggesting that a latent infection was not present. At 38 (rabbit S) and
47 (rabbit T) weeks post-infection, ROPV DNA but not ROPV transcripts
were detectable. In these two rabbits, presence of ROPV DNA suggested
Fig. 6. Real-time PCR detection of ROPV DNA and RNA transcripts. ROPV DNA copy number was assessed by real-time PCR relative to GAPDH reference gene in eleven ROPV-infected
rabbits. The average ratio of ROPV to GAPDH copy number from ﬁve tongue tissue samples is shown with standard error (A). Levels of E1^E4 transcript were also assessed in single
tissue samples for each rabbit. Samples marked by * had no ROPV DNA and/or E1^E4 transcripts detected. During latency, E1^E4 spliced transcripts were detected in ﬁve rabbits (N,
O, P, Q & U). Further RNA analysis was performed on tissues from these rabbits to detect and quantify transcripts originating from the E1, E2, E6 and E7 open reading frames (B). No-
RT controls were run for all samples andwere always negative (marked *). In addition to detecting spliced E1^E4 ROPV transcripts, RNA sequences originating from the E1, E2, E6 and
E7 open reading frames were detected in all of these ﬁve rabbits.
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due to the fact that only a single piece of tissuewas available for analysis
and a latent infection may not have established at this particular site.
When transcriptswere detected, their levels showedabroad correlation
with ROPV DNA-abundance. For the ﬁve post-regression rabbits where
spliced ROPV transcripts were apparent (rabbits N, O, P, Q and U), we
looked to see whether or not we could also detect RNA sequences
encoding the early proteins E1, E2, E6 and E7. Indeed sequences
corresponding to E1, E2, E6andE7open-reading framesweredetectable
in all rabbits. Levels of individual transcripts relative toGAPDHvariedby
less than 100 fold between rabbits (Fig 6B). Similarly, within the same
rabbit, levels of different transcripts varied less than 100 fold.
We next sought to demonstrate that the presence of ROPV transcripts
were speciﬁc to experimentally infected tongue sites and were not
detectable at sites that had not undergone scariﬁcation. To provide
sufﬁcient tissues for this experiment, a further two rabbits were infected
withROPVandculledat 24 weekspost-infection. Fivepreviously infected
and uninfected sites were analyzed using our RT-PCR assay for the
presence of spliced E1^E4 transcripts for each. Spliced ROPV transcripts
were detected at all ﬁve experimentally infected sites taken from both
rabbits but were not detected in samples taken from uninfected sites.
Thus the presence of splicedROPV transcriptswas as expected, speciﬁc to
tattoo-marked tissues and was not seen in adjacent uninfected tissues.
Presence of ROPV proteins in latently infected tissues
Following the regression of papillomas, we did not detect the
subsequent re-emergence of visible lesions in any of the rabbits
described in this study. Examination ofH&E stained tissue sections and
sections stained for L1 and E1^E4 from rabbits in the ﬁrst time course
experiment failed to show the presence of microscopic lesions or of a
low-level productive ROPV infection (Table 1). However, from our
analysis of ROPV DNA and transcripts during latency we cannot
discount the possibility that the virus undergoes sporadic activation to
form a low-level productive infection.We therefore undertook amore
thorough analysis of post-regression tissue sections in order to
determinewhether or notwe coulddetect ROPV late protein production
following papilloma regression by indirect immunoﬂuorescence stain-
ing. Four rabbits culled at 17, 22, 29 and 30 weeks post-infection (N, O, P
and Q respectively) were selected, from which ﬁve tattoo-marked
experimentally infected sites were available. Entire tattoo-marked sites
were sectioned and half of the sections stained with H&E and the other
half analyzed by immunoﬂuorescence using anti-L1 and anti-E1^E4
antibodies. In total, approximately 600 tissue sections were analyzed.
Evidence of viral protein expression was not apparent in any of the
tissue sections examined, suggesting an absence of microscopicproductive lesions (Fig. 7). In comparison, in papillomas harvested at
4 weeks post-infection, there was abundant E1^E4 expression in the
mid to upper epithelial layers primarily localized to the cytoplasm of
infected cells. In the upper layers of the epithelium toward the epithelial
surface, L1 protein was readily detectable. Therefore, in these four
latently infected rabbits, the presence of ROPVDNA and transcripts was
not associated with a production of new virions as determined by
immunoﬂuorescent detection of E1^E4 and L1.
Discussion
Our previous work has shown that ROPV represents a useful model
of low-risk mucosal HPV infection in humans (Peh et al., 2002). Such
low-risk HPV types are thought to cause latent infections of the upper
respiratory tract in patients suffering from recurrent respiratory
papillomatosis (Abramson et al., 2004; Steinberg et al., 1983), and of
the genital epithelium in individuals with genital warts (Lacey, 2005;
von Krogh et al., 2000). We therefore chose ROPV as a model system to
more thoroughly investigate papillomavirus latency. In this study we
optimized the ROPV infection procedure to allow the characterization of
life cycle events that follow immune regression of papillomas. Our
method of tattoo-marking experimentally infected sites has allowed us
to accurately identify sites of infection following regression, when
clinically detectable disease is no longer present. In all cases, papillomas
formed at the site of infection, and always underwent spontaneous
regressionwithin an8-week time frame. ThusROPVappears to provide a
reliable system in which to investigate the phenomenon of papilloma-
virus latency.
Following ROPV lesion-regression, we did not observe recurrence in
any rabbit as determined by visual inspection at regular intervals and
thoroughexaminationsof theoral cavity. Thus spontaneous reactivation
of ROPV leading to the re-emergence of clinical lesions appeared to be a
rare event in these immunocompetent animals. However, in the
absence of macroscopic lesions, we could detect ROPV DNA in tissue
samples taken from regions of the tongue that had undergone prior
experimental infection. Furthermore,we conﬁrmed that the persistence
of viral DNA was not associated with microscopic lesions in the
epithelium. Similarly, evidence of E1^E4 or L1 expression was not
apparent. The continued presence of viral DNA following the regression
of papillomas (in the absence of evidence of productive infection)
suggested to us that a latent infection had formed. It was also evident
that the persistence of viral DNAwas not anuncommonevent. Evidence
of latency was found in the great majority of tissue samples taken from
sites that had previously developed papillomas. We failed to detect any
residual ROPV DNA at all in only one rabbit. It is possible that in this
individual animal, a latent infection did not form at all. Alternatively, a
Fig. 7. Expression of E1^E4, L1 and MCM7 proteins in ROPV papillomas and latency. Tissue sections were obtained from ROPV papillomas and following regression of lesions during
latency. Detection of MCM7, E1^E4 and L1 proteins was performed by immunoﬂuorescence. In ROPV papillomas, expression of MCM7 was present from the basal layer of the
epithelium to themid layers, consistent with expression of E7 protein andmaintenance of cells in a proliferative state (panel A). Expression of E1^E4 protein started in themid layers
of the epithelium and overlapped for one or two cell layers with MCM7. Expression was present to the surface of the epithelium and was primarily cytoplasmic in location.
Expression of L1 capsid protein was observed in the upper layers of the epithelium consistent with new virion formation and was nuclear in location. Following the regression of
papillomas, an extensive analysis of tissue sections failed to demonstrate the presence of E1^E4 and L1 viral proteins (panel B). MCM7 expression was still present in a subpopulation
of basal epithelial cells only (panel B) and mirrored that of normal uninfected epithelium (panel C).
160 G.A. Maglennon et al. / Virology 414 (2011) 153–163latent infection may have formed but was subsequently eliminated,
either by the loss of latently infected cells or by clearance by the host
immune system.
Levels of viral DNA detected at latently infected sites were between
six and nine log fold lower than at sites bearing visible productive
papillomas. The marked differences in viral DNA copy numbers suggest
that signiﬁcant ampliﬁcation of viral DNAwas not occurring aswould be
expected in a productive ROPV infection. This explains our inability to
detectROPVDNAby in situhybridization followingpapilloma regression.
Analysis of tissue biopsies also suggested that only a small fraction of the
cells contained viral genomes. Because of the heterogeneous nature of
the biopsy material however, it was not possible to properly establish
copy number in the infected cells. To establish viral genome copy
number, our LCM approach was necessary.
Despite conﬁrming the continued presence of ROPV DNA in tissues
taken from sites of previous disease, our preliminary analysis did not
allow us to establish the particular location of latent infectionwithin the
epithelium. To overcome this limitation, we subsequently employed the
use of laser capture microdissection. The approach was optimized using
tissue sections containing productive papillomas and in these lesions we
could readily detect ROPV in the basal layers of the epithelium despite
not being able to detect DNA in these cells using ﬂuorescent in situ
hybridization. In contrast, we were unable to detect ROPV in the basal
epithelial cells of adjacent tissues that had not undergone experimental
infection. LCM and real-time PCR provided a means of detecting ROPVDNA in targeted populations of cells and with a sensitivity that we could
not achieve using other methods. Using this approach, we were able to
detect ROPV DNA in basal cells from around half of the experimentally
infected sites at intervals of up to 22 weeks post-infection. Microscopic
examinationof the tissue sections conﬁrmed that the basal cell ROPVwas
not associatedwitheithermicroscopic abnormalities in the epitheliumor
with the production of detectable levels of late viral proteins.
In the majority of basal cell samples analyzed, there was less than
one copy of ROPV per cell, demonstrating that not every cell contained
viral genomes. We hypothesize from this that the viral genome may
reside as a latent infection in a small subset of basal cells only. It is
possible that these “special” cells are epithelial stem cells as suggested
previously (Nicholls et al., 2001; Zhang et al., 1999). In contrast, we only
once detected a low DNA copy number in a sample taken from an
uninfected basal cell sample and not at all in any of the surrounding
mesenchymal tissues examined. Interestingly, thepresence of viral DNA
in the basal layers of the epithelium was typically not associated with
viralDNA in remainingupper layers of the epithelium. This suggests that
latency can occur without genome ampliﬁcation in the upper layers of
the epithelium, and is supportive of our inability to detect completion of
the virus life cycle. In one case however, we did detect a three-log fold
ampliﬁcation in viral DNA upon differentiation; a result which remains
to be properly explained. Although this was less than the ﬁve-log fold
ampliﬁcation typically seen in productive papillomas, the examination
of adjacent tissue sections showed this ampliﬁcation to be in the
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Thus, it is possible that occasional and sporadic low level ampliﬁcationof
latent viral DNA may occur in a small number of cells.
We sought to determinewhether or not the persistenceof ROPVDNA
in the absence of clinical lesions was associated with viral transcription.
ROPV genome-persistence was associated with production of spliced
transcripts spanning the major E1^E4 splice site. Levels of transcripts
mirrored the levels of ROPV DNA, and were detectable as late as 1 year
post-infection. We detected spliced RNA transcripts in the majority of
rabbits tested. Spliced transcripts were speciﬁc for experimentally
infected sites, indicating that transcripts had not arisen as a result of
contamination from elsewhere within the oral cavity. Transcripts were
detected at all infected sites examined, suggesting that a low level of
transcription was in fact a common occurrence during latency. We also
determined the presence of transcripts arising from theE1, E2, E6 andE7
open reading frames. A previous study showed that asymptomatic
infection of domestic rabbits with CRPVwas associated with production
of E1 transcripts and that subsequent activation led to detection of E6
and E7 transcripts (Zhang et al., 1999). Similar ﬁndings were made in
tissues obtained from patients with HPV-11 associated recurrent
respiratory papillomatosis, where in the absence of clinical lesions, E1
and E2 transcripts were detected (Maran et al., 1995). Indeed we also
found that both E1 and E2 transcripts were detected in all rabbits
examined.However,wealso concurrentlydetectedE6 andE7 transcripts
in rabbit tissues. These results were not surprising given that E6 and E7
transcripts as well as E1 and E2 transcripts have been shown to be
necessary for the stable maintenance of genomes for some papilloma-
virus types (Oh et al., 2004; Thomas et al., 1999).
Despite detecting low levels of RNA transcripts in latently infected
tissues, we did not detect the presence of late viral proteins by
immunoﬂuorescence. L1 and E1^E4 proteins were abundantly
expressed in the epithelium during productive ROPV infection, but we
failed to detect protein in our rigorous analysis of around 600 tissue
sections taken from latently infected rabbits. Our ﬁndings suggest that
ROPV persists in a true latent state without the production of new
virions. However, although we did not detect ROPV protein, we cannot
completely exclude the occurrence of sporadic instances of productive
infection (as suggested by the single ﬁnding of high ROPV copy numberFig. 8. A model of papillomavirus latency following immune regression. An active infectio
epithelium. Cells in the basal layer and above are driven into cell cycle allowing genome amp
Viral strategies, such as low level protein production in the lower epithelial layers, assist the
immune regression, accompanied by inﬁltration of predominantly T cells. Viral gene express
restricted to stem cells in the basal layer of the epithelium. Reactivation of latency is prev
reactivation to occur. Completion of the virus life cycle may or may not be associated within the upper layers of one latent infection). It is possible that latent ROPV
does occasionally reactivate, but that a low level burst of productive
infection ensues that is subsequently suppressed by the immune system.
Detection of such bursts would require frequent analysis of tissues from
individual rabbits, and possibly also the collection of sequential biopsies.
Suchanalysiswasprohibitedby the small size of the tongueand the small
number of sites that could be infected. Although we did see evidence of
apparent ROPV DNA ampliﬁcation in a tissue sample obtained from one
latently-infected rabbit, the analysis of adjacent sections by immunoﬂuo-
rescence failed to demonstrate the presence of L1 or E1^E4 protein.
In this study, we demonstrate that ROPV can persist at sites of
experimental infection following the immune-mediated regression of
papillomas. We believe that such persistence is in the form of a latent
infection and that subsequent reactivation may be a source of recurrent
disease and virus production. It is possible that spontaneous reactivation
could occur, althoughwe did not observe this in any of the rabbits in this
study. According to our proposed model of papillomavirus latency
(Fig. 8), factors external to the cell (e.g. wound healing, hormone levels)
may enhance the ability of latent infections to reactivate, and it is likely
that the immune system is of central importance to maintaining
papillomavirus infection in a quiescent state. Modulation of immunity,
for example by inductionof immunosuppression,may allowreactivation
to occur. We are currently investigating whether or not drug-induced
suppression of the adaptive immune system can lead to reactivation of
ROPV in experimentally infected rabbits.
Materials and methods
Infection of rabbits
All animal experiments were performed in accordance with the
relevant legislation in the United Kingdom and with local ethical
approval. A crude virus suspensionwas prepared fromROPV papillomas.
Brieﬂy, mature papillomas were harvested from the tongue of a rabbit
that had undergone experimental infection with ROPV (a gift of Neil
Christensen, Pennsylvania StateUniversity, USA) andwerehomogenized
in phosphate buffered saline using an electric rotor-stator homogenizer
to form a 10% (w/v) suspension. Virus suspensionwasmixed 50:50withn follows entry of papillomavirus into an epithelial stem cell in the basal layer of the
liﬁcation and new virion production to occur in the intermediate and upper cell layers.
virus in evading immune detection. Triggering of an effective immune response leads to
ion is shut off and lesion regression occurs. Viral latency may ensue with viral genomes
ented by host immune surveillance. Factors such as immune suppression may allow
reappearance of a visible lesion.
Table 3
Location Primer/
probe
Sequence Annealing
position
ROPV L1 Forward
primer
CAC-TGT-CAT-GAA-CAT-TGT-CAC-AAA-G 6798–6722
ROPV L1 Reverse
primer
TTG-AAA-GCA-TTG-TTA-GCC-CAA-GT 6747–6769
ROPV L1 TaqMan
probe
CGA-ATG-GCA-ATG-GCG-CAG-TTG-A 6724–6745
GAPDH Forward
primer
GGA-TTT-GGC-CGC-ATT-GG N/A
GAPDH Reverse
primer
CAA-CAT-CCA-CTT-TGC-CAG-AGT-TAA N/A
GAPDH TaqMan
probe
CGC-CTG-GTC-ACC-AGG-GCT-GC N/A
ROPV E1 Forward
primer
CAG-TGG-GTG-GTT-TTT-AGT-GAC-TGA 1175–1198
ROPV E1 Reverse
primer
CAG-TTC-CTC-AAA-CTC-ATC-GTC-AAA 1227–1250
ROPV E1 TaqMan
probe
GCA-GAC-TGT-GTG-GAT-GGA-GTA-CCG-
GA
1200–1225
ROPV E2 Forward
primer
GGA-ATT-TGA-TCA-GGA-AAG-AGC-AA 3032–3054
ROPV E2 Reverse
primer
TTC-CCA-AGC-GCC-TTA-TGC 3083–3100
ROPV E2 TaqMan
probe
TTA-TAT-TGC-ACT-TTG-CCA-GAA-AAC-AT 3056–3081
ROPV E6 Forward
primer
CCA-ACA-CAG-CCT-TTG-TGC-AA 567–586
ROPV E6 Reverse
primer
CTA-CAG-TAA-CTA-AAG-GTG-CTG-CTT-
CTG
613–639
ROPV E6 TaqMan
probe
TGC-AGC-TTT-TGC-AGC-CCA-TTG-C 588–609
ROPV E7 Forward
primer
TGA-GCG-TGT-GGA-TGA-TAT-AAT-TCT-G 932–956
ROPV E7 Reverse
primer
CAC-ACT-CTA-CTA-CTA-TAA-GAT-AAG-
CTG-AAT-GC
986–1017
ROPV E7 TaqMan
probe
GAG-GAG-GAT-CAG-CAG-GGC-AAA-
CAG-G
960–984
ROPV
E1^E4
Forward
primer
GCG-CCG-CAA-ACG-TCT-GAA-AAA-T 1123–1144
ROPV
E1^E4
Reverse
primer
AAC-CGG-CCC-CGA-TAA-CGA-CTT-GAC 3646–3669
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speciﬁed pathogen free rabbits (Harlan Ltd, UK) were anaesthetized
using a combination of ketamine hydrochloride (20 mg/kg), buprenor-
phine hydrochloride (0.05 mg/kg) and medetomidine hydrochloride
(0.25 mg/kg) administered by subcutaneous injection. A 23-gauge
hypodermic needle was loaded with ROPV by dipping it into the virus
suspension. Holding the needle at 90 degrees to the tongue surface,
individual punctures were made on the ventral aspect of the tongue.
Residual tattoo ink was removed with tissue paper. A further 20 μl of
crude virus suspension were added and allowed to “dry in” for several
minutes. Anesthesia was partially reversed by administration of
atipamezole hydrochloride (1.25 mg/kg) by subcutaneous injection.
Tissue samples
Animals were culled by intravenous injection of 20% pentobar-
bitone sodium (200 mg/kg) and the tongue dissected free. Tissues
destined for DNA and RNA analysis were dissected using sterile
disposable instruments and snap frozen in a mixture of dry ice and
isopentane. For tissue sectioning, samples were embedded in OCT
compound (CellPath Ltd, UK) prior to snap freezing. DNAwas extracted
from up to 25 mg tongue tissue using a DNAMicro Kit (Qiagen Ltd, UK)
according to the manufacturer's instructions. Total RNA was extracted
from up to 100 mg tongue tissue ground to a ﬁne powder under liquid
nitrogenusing aPureLinkRNAMiniKit (Invitrogen Ltd,UK) according to
the manufacturer's instructions. To prepare cDNA from RNA, rigorous
DNase treatment of total RNA was ﬁrst performed twice using Turbo
DNA-Free (Ambion Ltd, UK) according to the manufacturer's instruc-
tions. Random hexamer primed reverse transcription was then
performed using a SuperScript III First Strand Synthesis kit (Invitrogen
Ltd, UK) according to the manufacturer's instructions.
Laser capture microdissection
Tongue tissueswere sectionedevery8 μmonto1 mmPENmembrane
slides (Zeiss Ltd, UK) and stained with hematoxylin and eosin. Laser
dissection was performed using a PALM MicroBeam system with an
ultraviolet laser (Zeiss Ltd, UK). Groups of cells were dissected (typically
between 200 and 1000) and captured in 200 μl Adhesive Cap
microcentrifuge tubes (Zeiss Ltd, UK). Sampleswere incubated overnight
at 56 °C with 50 μl digestion buffer (10 mM Tris, 1 mM EDTA, 0.1%
Tween-20, pH8.0) with 20 μg proteinase K followed by incubation at
95 °C for 10 min. Five microliters of sample were used as template for
real-time PCR reactions.
Detection and quantiﬁcation of DNA
Real-time PCR was used for the detection and quantiﬁcation of
DNA and cDNA. For the detection of rabbit GAPDH, ROPV genomic
DNA and E1, E2, E6 and E7 cDNA, the TaqMan probes and oligonucle-
otide primers shown in Table 3 were used. Reactions were prepared
in a volume of 25 μl containing 1× TaqMan Universal PCR Mastermix
(Applied Biosystems Ltd, UK), 40 nM of each primer and 100 nM
TaqMan probe. For detection of spliced E1^E4 cDNA, a suitable TaqMan
probe could not be designed, therefore SYBR Green chemistry was
employed using the primer pair shown in Table 3. Reactions were
prepared in a volume of 25 μl containing 1× Absolute SYBR Green QPCR
Rox Mix (Applied Biosystems Ltd, UK) with 100 nM each primer. PCR
was performed using an ABIprism 7500 system with 15-min denatur-
ation at 95 °C followed by 40 cycles of 95 °C for 15 s and 60 °C for 60 s.
For each real-time PCR assay, a standard curve experiment was
performed to allow absolute quantiﬁcation of DNA. For ROPV genomic
DNA and E1, E2, E6 and E7 cDNA, a pUC19 plasmid containing ROPV
genome (a kind gift of Neil Christensen, Pennsylvania State University,
USA)was used as template. For rabbit GAPDH, a 300 bp fragment of the
rabbit GAPDH gene (Genbank accession L23961)was ampliﬁed by PCR(forward primer sequence ttcgacaggcagccgcttcttctc, reverse primer
sequence ctcggcaccagcatcaccccactt) and cloned into the pDrive vector
(Qiagen Ltd, UK) according to the manufacturer's instructions. For the
detection of spliced E1^E4 cDNA, a ~1200 bp DNA fragment was
ampliﬁed by PCR from spliced E1^E4 cDNA (forward primer sequence
cgccgctgtctttgggggataa, reverse primer sequence aaccggccccgataac-
gacttgac) and cloned into pDrive vector. Serial dilutions of plasmid
DNA were prepared and plots of DNA copy number against cycle
threshold value used to determine standard equations. All real-time PCR
reactions were run in triplicate along with no-template controls. For
determinationof cDNAcopynumber, identical reactionswere runminus
reverse transcriptase enzyme to control for the ampliﬁcation of viral
DNA and these were always negative. For E1, E2, E6, E7 and ROPV DNA,
we determined our assays to be sensitive for the detection of plasmid
DNA down to at least eight copies. Our E1^E4 assay was sensitive down
to at least 11 copies. Additionally, we demonstrated the sensitivity of our
ROPV DNA assay in detecting two copies of ROPV plasmid DNA in rabbit
genomic DNA samples extracted from tongue tissue. Efﬁciency values of
real-timePCRampliﬁcationwere similar for each assay asdeterminedby
standard curve analysis. In particular, efﬁciency values for GAPDH and
ROPV DNA were −3.2 and −3.27, with a value of −3.3 indicative of
100% efﬁciency.
For determination of ROPV DNA in whole tissue biopsies, ROPV DNA
copy number was expressed relative to GAPDH copy number. Whole
tissue biopsies contained a heterogeneous population of dermal, stromal
and epithelial cells many of which are not susceptible to infection with
ROPV, therefore a “copy per cell” value would be inaccurate. Similarly,
cDNA copy numbers are expressed relative to copy number of GAPDH
163G.A. Maglennon et al. / Virology 414 (2011) 153–163cDNA. For LCM samples, DNA was extracted from known cell numbers.
We determined our real-time PCR assay for GAPDH to amplify 20–30
copies of GAPDH per cell indicating the presence of numerous
pseudogenes. Extraction of DNA from samples containing known
numbers of peripheral blood leukocytes conﬁrmed that 26 copies of
GAPDHwere ampliﬁed per cell. For LCM samples, a copy number per cell
of ROPV DNA was therefore possible.
Immunoﬂuorescence
Tissueswere sectioned every 6 μmona cryostat andstored at−80 °C
until use. Sectionswere allowed towarm to room temperature and then
ﬁxed in ice-cold methanol (MCM7) or acetone (L1 and E1^E4) for
10 min. Sectionswere placed in phosphate buffered saline for 5 min and
then blocked in 10% fetal calf serum for 20 min. Endogenous peroxidase
activity was blocked by incubation of slides in 3% hydrogen peroxide for
6 min.Antibodieswerediluted in3%bovine serumalbumin inphosphate
buffered saline. Mouse monoclonal anti-L1 (clone K1H8, Dako Ltd, UK)
was added at 1:50 andmouse monoclonal anti-MCM7 (Fisher Scientiﬁc
Ltd, UK) at 1:100 dilution overnight at 4 °C. A biotinylated anti-mouse
IgG antibody (Vectorlabs Ltd, UK) was added at 1:100 dilution for 1 h
followed by incubation with a streptavidin-biotinylated-HRP complex
(Vectastain-ABC, Vectorlabs Ltd, UK) for 30 min according to the
manufacturer's instructions. HRP activity was localized and ampliﬁed
using a Tyramide Signal Ampliﬁcation Kit (Perkin-Elmer Ltd, UK)
according to the manufacturer's instructions and a DAPI nuclear
counter-stain applied. For double-staining of E4 protein, a rat polyclonal
antibody raised against an ROPV E1^E4 and glutathione-S transferase
fusion protein was added at 1:50 dilution for 4 h (Peh et al., 2002). A
ﬂuorophore-conjugated anti-rat IgG secondary antibody (Alexa-Fluor
488, Invitrogen Ltd, UK) was added at 1:150 dilution for 60 min.
In situ hybridization
Tissues sectioned every 6 μm on a cryostat were ﬁxed in 4%
paraformaldehyde for one hour at room temperature. Sections were
incubated in proteinase K solution (50 μg/ml) for 20 min at 37 °C
followed by 3% hydrogen peroxide for 6 min at room temperature. Full
length ROPV genomic DNA cloned into a pUC19 vectorwas labeledwith
digoxigenin (DIG) using a DIG DNA Labeling Kit (Roche Applied Science
Gmbh, Germany) according to the manufacturer's instructions. Labeled
probe diluted to 40 pg/μl in hybridization buffer (50% formamide, 5%
dextran sulphate, 1× Denhardt's solution, 4× SSC, 200 μg/ml salmon
spermDNA)was added to sectionswith a cover slip and heated to 95 °C
for 5 min followed by cooling on ice for one minute. Hybridization was
performed at 42 °C overnight in a humid box. The following day, cover
slips were removed and the slides washed for 10 min in formamide
wash buffer (50% formamide, 2× SSC, 0.05% Tween-20) followed by
10 min in 2× SSC both at 42 °C. Non-speciﬁc binding of antibody was
prevented by blocking sections in 10% fetal calf serum for one hour. An
anti-DIG HRP-conjugated antibody (Roche Applied Science Gmbh,
Germany) was added at 1:400 dilution for one hour. HRP activity was
localized and ampliﬁed using a Tyramide Signal Ampliﬁcation Kit
(Perkin-Elmer Ltd,UK) according to themanufacturer's instructions and
a 4',6-diamidino-2-phenylindole (DAPI) nuclear counter stain added.
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